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A B S T R A C T   
The erythrocytes obtained from patients diagnosed with Plasmodium falciparum or Plasmodium vivax infection 
(two groups of five patients each) and treated in the Department of Infectious Diseases, University Hospital in 
Kraków, were measured using the Raman spectroscopy method (1–2 cells of each patient) and then compared 
with the results from these patients during their convalescence. Principal Component Analysis (PCA) was used to 
determine the variance between the Raman spectra. Changes in the heme structure were observed by the v4 
oxidation state marker and by other heme and hemozoin marker bands, as well as protein side chains marker 
bands. The recognized Raman bands allow to differentiate changes taking place in the red blood cells during the 
development of Plasmodium falciparum from Plasmodium vivax. The 1385 cm− 1 Asp band along with the 1587 
cm− 1 Gln vibrations at the beginning of hospitalization specify the invasion of P. falciparum that occurs with the 
basigin receptor which requires respective protein glycosylation. The 1361 cm− 1 and 1544 cm− 1 Trp bands 
indicate the invasion stage of the P. vivax parasite, and the formation of the ligand-receptor complex. To our 
knowledge, this is the first Raman spectroscopic observation that we can distinguish Plasmodium species.   
1. Introduction 
Malaria is still one of the most deadly infectious diseases, that affects 
more than 500 million people annually, causing between 1 and 3 million 
deaths. According to the World-malaria-report-2019 most malaria cases 
in 2018 were in the African Region (93%), then in the South-East Asia 
Region 3.4% cases, and next in the Eastern Mediterranean Region with 
2.1% [1]. Children aged under 5 years are the group affected by malaria 
with the most risk. In 2017, the 61% of all malaria deaths worldwide 
were reported in this group. 
In Poland malaria was endemic up to the middle of 60th years of the 
20th century [2]. Since then, malaria transmission has not been 
observed. Nowadays people that are infected with malaria are usually 
travelers, workers coming back home for holidays, students returning 
from international exchanges, soldiers serving on peace-keeping mis-
sions and missionaries [3,4]. In the last report of the National Institute of 
Public Health, Poland, in 2019 there were 24 cases of malaria reported, 
in 2018 there were 28 cases. Fortunately no fatal cases were noticed [3]. 
Malaria is an infectious disease caused by Plasmodium parasites. 
Humans are the intermediate host for Plasmodium, infected female 
Anopheles mosquitoes are malaria vectors. There are five parasite species 
that cause malaria in humans, and two of these species – P. falciparum 
and P. vivax – cause the greatest threat. It is known that P. falciparum is 
the most dangerous malaria agent, while P. vivax is a cause of mostly 
non-severe malaria [5–7]. This assessment is due, inter alia, to the fact 
that the actual data on P. vivax mortality are still uncertain [8–10]. 
The first symptoms of infection – fever, headache, and chills – may be 
mild and difficult to recognize as malaria. The technique which remains 
as a “gold standard” in diagnostics is an examination under the micro-
scope a drop of the patient’s blood, spread out as a blood smear on a 
microscope slide [11,12]. Prior to examination, the specimen is stained 
(with the Giemsa method) to give the parasites a distinctive appearance. 
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This method allows the malaria diagnosis, as well as monitoring the 
treatment. Early diagnosis and treatment of malaria reduces disease 
progression and mortality [13,14]. It also contributes to reduce malaria 
transmission. The distinction between the Plasmodium is important for 
treatment selection and patient’s prognosis [15,16]. Therefore, many 
efforts are taken to find a proper and quick diagnostic method of ma-
laria. For example, research is being conducted into the diagnostic 
application of spectroscopic methods [17]. 
P. falciparum and P. vivax exhibit some different features of the life 
cycle. It may be a reason of other specificity of changes in erythrocytes 
due to parasite heterogeneity [18–22]. Feature allowing to differentiate 
these two malaria species is the fact that Plasmodium vivax forms hyp-
nozoite forms in humans liver [23] and that their erythrocyte cycle 
occurs mainly in reticulocytes [24]. Another difference in the life cycle 
of P. vivax compared to P. falciparum is the rate of gametocyte devel-
opment. In the case of P. vivax, this process occurred rapidly [25]. 
Raman spectroscopy traces successfully heme modification during 
the asexual erythrocyte cycle. The merozoite invades the host’s red 
blood cell, creating a food vacuole separated from the host cell’s cyto-
plasm [26]. Degradation of hemoglobin begins already in the 
ring-phase, but the vast majority of degradation occurs in the 6–12 h 
stage of trophozoite. The heme concentration in the food vacuole 
quickly becomes remarkably high, and the consequence of the elevated 
heme concentration oxidative stress is increased [26,27]. Trophozoites 
contain an activity that catalyzes the formation of hemozoin and this 
process also detoxifies the heme (which is toxic for Plasmodium) [28]. 
Apart from the changes taking place in the heme structures of the 
infected erythrocyte by Plasmodium also other changes were successfully 
observed by Raman spectroscopy. It introduces disorder in the phos-
pholipids of erythrocytes membrane. Trans configuration, characteristic 
for healthy red blood cells, transforms and the number of gauche con-
formers increases, therefore the membrane molecular arrangement 
leads to changes in the structure and fluidity [4,29–31]. The C-C back-
bone and C-H stretching vibrations of the trans and gauche conforma-
tions differ and the corresponding marker bands appear at different 
wavenumber positions in the Raman spectra [29,31–33]. Plasmodium 
invasion proceeds through a series of complex stages of receptor-ligand 
interaction [6,34]. This activity of the parasite triggers the movement of 
numerous proteins through a series of membranes inside the cell and 
through the cytoplasm. Plasmodium spp. introduced theirs own proteins 
into erythrocyte plasma membrane in the first seconds of the invasion of 
the erythrocytes, in the phase of strong binding and finally in internal-
ization [21]. P. falciparum Erythrocyte Membrane Protein 1 (PfEMP1) is 
the major virulence factor on the surface of P. falciparum-infected RBCs 
[35,36]. A biological analysis has shown that the majority glycoproteins 
are associated with virulence factors of medically significant pathogens 
[37]. The membrane protein which is characteristic for P. vivax invasion 
is Transferrin receptor (TfR) [38]. This protein is rich in Tryptophane 
[39,40]. 
In the present study, we have examined the erythrocytes obtained 
from patients diagnosed with P. falciparum or P. vivax infection at the 
Department of Infectious and Tropical Diseases, University Hospital in 
Kraków, and then compared it with the medical results obtained from 
these patients during their convalescence. The aim of this work was 
both- to study RBC across the patients recovery as well as comparing 
P. falciparum vs P. vivax effect on erythrocyte. This work seems to be 
unique due to Raman measurements performed on samples taken from 
patients blood. It is especially valuable for P. vivax as there is limited 
posibility to culture P. vivax in vitro [41,42]. Although the Plasmodium 
affect similar on RBCs [43,44], but we expect that the recognized Raman 
bands will allow us to distinguish changes in red blood cells during the 
development of P. falciparum, in relation to P. vivax. To our knowledge, 
this is the first observation in which we can distinguish Plasmodium spp. 
by analyzing their activity through their influence on the erythrocytes of 
hospitalized patients using Raman spectroscopy. This could contribute 
to a different and perhaps faster diagnostics carried out in parallel with 
traditional methods. 
2. Materials and methods 
2.1. Patients and medical standard diagnostic tests 
The patients who took part in our research were cases with imported 
malaria from African and Asian endemic regions: two African students 
studying in Poland, three tourists, two people working in endemic areas, 
two medical mission volunteers and one missionary, see Fig. 1. They 
were hospitalized at the University Hospital the Department of Infec-
tious Diseases in Kraków. Two types of malaria were diagnosed - caused 
by P. falciparum and P. vivax, two groups of five patients each were 
studied using Raman microspectroscopy method. Standard medical 
procedures, tests and treatment, were performed according to the 
generally accepted methods. The suspicion of malaria was made based 
on the patient’s travel history, symptoms, and the physical findings at 
examination, laboratory tests, and malaria rapid diagnostic tests 
(OptiMAL-IT Rapid Malaria Test Kit, Bio-Rad, France). For a definitive 
diagnosis the malaria parasites were identified by microscopic exami-
nation. In whole research group there were 21 patients, 15 diagnosed 
with P. falciparum and 6 with P. vivax. The most severe course was 
analysed in 5 patients in each group. 
These studies were conducted in accordance with the guidelines for 
good clinical practice (GCP) and according to Ethical Principles for 
Medical Research Involving Human Subjects (Declaration of Helsinki). 
The study was approved by the local Bioethics Committee. 
2.2. Blood samples for Raman measurements 
The blood from patients with malaria was obtained by venipuncture 
at the beginning of hospitalization, and also from these patients as they 
were recovering, at the end of hospitalization. The blood was placed in 
tubes containing heparin as an anti-coagulant and was transported to the 
Raman laboratory without delay. Then it was deposited as a blood film 
so that it could be measured. The cells were allowed to settle for about 
ten minutes prior to measurement. 
2.3. Raman microspectroscopy 
A Renishaw inVia spectrometer, working in a confocal mode, con-
nected to a Leica microscope, was used for the measurement of a single 
cell Raman spectrum. The beam from a 514.5 nm Ar+ ion Modu Laser 
was focused by a 100 × magnifying, high numerical aperture (NA = 0.9) 
top class Leica objective for standard applications. Raman light was 
dispersed by a diffraction grating with 2400 grooves per mm. The laser 
power was kept low, ca. 1–3 mW at the sample, to ensure the minimum 
invasion to the cells. Pre-processing of Raman spectra, smoothing and a 
baseline correction, was performed with the Renishaw WiRE 3.4 and 2.0 
software. 
Fig. 1. Map showing malaria cases analyzed in the work, P. falciparum (red 
dots), P. vivax (blue dots). 
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2.4. Statistical analysis of the results of medical standard diagnostic tests 
The results of the blood morphology for the entire research group 
and also for severe cases were statistically analyzed by calculating the 
arithmetic mean of the results and the standard population deviation 
function in Excel software. These data, presented in the form of graphs, 
are included in the Supplementary materials, Figs. S1–S3. 
2.5. Principal component analysis 
Principal Component Analysis (PCA) allows for the determination of 
the variance between the Raman spectra of a single RBCs of patients, 
with identified P. falciparum or P. vivax infection, obtained at the 
beginning of hospitalization (90 and 78 spectra, respectively), and also 
as patients were recovering, at the end of hospitalization (119 and 112 
spectra, respectively). Investigation of the collected spectra were made 
within one Plasmodium species evaluating the beginning and the end of 
hospitalization. Additionally there were performed analyses comparing 
the modifications of the red blood cells by the two Plasmodium species . A 
PCA was performed and discussed in the four spectral regions using 
Unscrambler X software packages (v. 10.3, CAMO Software, Oslo, Nor-
way). The Raman spectra were pre-processed: smoothed using a 
Savitzky–Golay smoothing algorithm (thirteen smoothing points), 
baseline corrected and unit vector normalized. 
3. Results and discussion 
3.1. Malaria and the results of the selected medical tests 
As it was mentioned before for malaria definitive diagnosis, treat-
ment planning and monitoring, the microscope identification of blood 
smear with Giemsa staining should be performed. The results of % 
parasitemia for all patients who participated in the study is presented in  
Fig. 2. In Fig. 2A there is showed the mean parasitemia for all patients 
with P. falciparum and with P. vivax, the red and blue line, respectively. 
In Fig. 2B there is the parasitemia obtained from the patients with the 
most severe course of the disease. It can be observed that for patients 
infected by P. falciparum there is a much higher parasitemia level, 
especially in the case of the patient with the most severe course of the 
disease (Fig. 2B). 
Other selected laboratory results of the malaria patients are pre-
sented and commented in Supplementary material. 
3.2. The appearance of the invaded red blood cells 
Structural changes, resulting from the invasion of red blood cells by 
malaria parasites, are also associated with alteration in the appearance 
of infected erythrocytes, see Fig. 3. 
The cells into which the parasite has invaded, compared to normal 
erythrocytes, are more rigid, less deformable and they appear more 
rounded and convex [45]. These features can lead to their complete 
immobilization in the microcirculation and in conjunction with adhe-
sion appear to be a critical process for the maintenance of parasite 
virulence [29]. The stiffening of the RBC cell skeleton was observed as 
an effect of the action of other toxins as well [46]. It is believed that 
cytoadherence may have evolved to minimize the exposure of rigid 
parasitic cells in the spleen, thus minimizing spleen sequestration and 
destruction [45]. It is the subject of research whether modifications of 
the mechanical properties of erythrocytes are related to the growth of 
the parasite and the export of its proteins through the membrane or are 
they essential for the development of the parasite [47]. 
3.3. Raman microspectroscopy results 
Raman spectra obtained from data averaged on a first and tenth day 
of hospitalization for the representative patients diagnosed with 
P. falciparum and P. vivax are presented in Fig. 4. Spectra for Plasmodium 
infected red blood cells are similar, it is difficult to identify the char-
acteristics associated with a particular species of parasite. The leading 
difference is related to the structure of oxy- and deoxy- hemoglobin 
vibrations, resulting from the activity of the Plasmodium and conse-
quently leading to changes in the red blood cells. Band assignments were 
carried out by recognizing and characterizing the vibrations of metal-
loporphyrins that model heme vibrations, see Table S1 [48–53]. How-
ever, the specificity of resonance excitation on the 514.5 nm line, close 
to Q0–0 band, is a decrease in relative intensity of the ν2, ν3 and ν4 
symmetric modes, so the intensity enhancement may not seem so sig-
nificant [54]. Although the blood was collected and measured on the 1st 
day of patient hospitalization, the various stages of malaria parasite 
development cannot be excluded. On the last 10th day of hospitalization 
of the treated patients, the effects of parasite activity should disappear, 
which determines a parasitemia level equal to zero. 
The representative spectra from the first and the last day of hospi-
talization, for both of the studied types of parasitic protozoa of the genus 
Plasmodium were compared in Fig. 4. The PCA model was built on the 
basis of RBCs Raman spectra of patients infected with P. falciparum and 
P. vivax, at the beginning and at the end of hospitalization, which gave 
Fig. 2. The parasitemia during the course of the treatment of the malaria 
infected patients. The red line shows the levels for the patients diagnosed with 
Plasmodium falciparum, the blue one- Plasmodium vivax; (A) average results for 
all patients (B) data from the patients with the most severe course of 
the disease. 
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four correlations, Pf1 (P. falciparum the 1st day of hospitalization) vs 
Pf10 (P. falciparum the 10th day of hospitalization), Pv1 (P. vivax the 1st 
day of hospitalization) vs Pv10 Pv1 (P. vivax the 10th day of hospitali-
zation), Pf1 vs Pv1 and Pf10 vs Pv10, that are presented in Figs. 5–8, 
respectively. The characteristics of the spectra are discussed in the four 
spectral ranges, the 1200–1000 cm− 1 and 3000–2850 cm− 1 regions 
sensitive to the conformation of the hydrocarbon chains and the inter- 
chains interactions, respectively, the next region 1500–1200 cm− 1 of the 
pyrrole ring stretching and CH2/CH3 deformation and the 
1700–1500 cm− 1 region of the core size marker bands. 
3.4. PCA analysis of the Raman microspectroscopy data 
3.4.1. C–C stretching vibration region (1200–1000 cm− 1) 
This spectral region includes the acyl backbone C–C bonds vibrations 
sensitive to the phospholipids molecular arrangement [32]. In this 
spectral range there are also bands characterizing heme vibrations [48, 
49]. The PCA scores plots (Fig. 5A, 6A, 7A, 8A) show the separation 
based mainly on differences in the structurally sensitive bands found in 
this region. 
Pf1 vs Pf10. The C-C stretching region shows a clear separation for 
the 1st and 10th day of P. falciparum infected patient data in the PC-1 vs 
PC-3 scores plot, Fig. 5A. The band at 1080 cm− 1 observed on the 1st 
hospitalization day is due to the νCC gauche conformer vibrations, while 
at 1068 cm− 1 it is assigned to the νCC trans conformation and typifies 
the process of returning to the health balance of the erythrocyte mem-
brane. The 1102 cm− 1, PO2- symmetrical stretching of the phospho-
lipids, observed for the 1st day is shifted to a lower frequency 1090 cm− 1 
on the 10th day. This describes that disorder still present in the mem-
brane phospholipids assemblages [32]. Other minima bands in the PC-3 
loadings, 1037 cm− 1 (Ser), 1138 cm− 1 (Asp), 1152 cm− 1 (Thr), are 
assigned to amino acid residues associated with the invasion of the 
parasite and with the foreign proteins introduced into the membrane 
(Table 1). 
Pv1 vs Pv10. The PC-1 vs PC-2 scores plot shows the separation of Pv1 
and Pv10 data (Fig. 6 A). The similar minima positions in the PC-2 
loadings plot, slightly shifted in relation to the correlation for 
P. falciparum, describe the Pv1 group (Table 1). It can be seen, however, 
that the data characterizing Pf10, due to some ambiguity, do not give a 
picture of a fully healthy membrane. 
Summing up these two cases the Raman spectra from the first days of 
hospitalization for both Plasmodia, Pf1 and Pv1, are characterized by a 
higher presence of gauche conformers, while the last examined day, the 
Pf10 and the Pv10, contain more trans conformers. 
Pf1 vs Pv1. The obtained PCA resulting in the PC-3 vs PC-4 scores 
plot, shows a distinction between the two groups of Plasmodia infected 
RBCs, P. falciparum and P. vivax, at the beginning of hospitalization 
(Fig. 7 A). The maxima in the PC-3 position loadings in the first days 
indicate wavenumbers of 1032 cm− 1 (Ser), 1130 cm− 1 (CC trans, PE), to 
P. vivax, while minima 1147 cm− 1 (Asp, Glu), 1189 cm− 1 (Tyr, Ser) and 
also 1170 cm− 1 (Tyr, Ser) distinguishes P. falciparum. This dependence 
draws attention the signals from the amino acids influencing the 
recognition of the Raman spectra of blood cells changed under the in-
fluence of P. falciparum and P. vivax at the beginning of the infection. 
Pf10 vs Pv10. The last day of hospitalization shows a clear separation 
of the data of both types of Plasmodium infected RBCs according to the 
PC-2 main component with a relatively high 26% variation (Fig. 8 A). 
The P. falciparum effect is characterized by the bands 1025 cm− 1 (Ser), 
1066 cm− 1 (Arg) and 1090 cm− 1 (νCC gauche), while the P. vivax is 
Fig. 3. Microphotographs of infected RBC with (A) P. falciparum, (B) P. vivax, the first day of hospitalization.  
Fig. 4. Raman spectra showing the most prominent peaks in the ranges of 
1900–1000 cm− 1 and 3200–2300 cm− 1 of RBCs patients infected with, (A) 
P. falciparum, (B) P. vivax, the 1st day of hospitalization, and (C) P. falciparum, 
(D) P. vivax, the 10st day of hospitalization, excitation laser line at 514.5 nm; 
100 × magnification objective (NA= 0.90) [29,31,48–55,59]. 
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characterized by the bands 1124 cm− 1 (ν22) and 1170 cm− 1 (Ser, Tyr). 
3.4.2. The C–H stretching vibration region (3000–2850 cm− 1) 
In the area of the C-H stretching vibrations, inter-chain vibrations 
occur, which supplement information about the intra-chain C-C vibra-
tions occurring in the area discussed earlier, enriching the obtained 
structural information concerning the membrane of the infected eryth-
rocytes [32]. Bands at 2933 cm− 1and 2872 cm− 1 are assigned to the 
symmetric and antisymmetric C–H stretching vibrations of the methyl 
and methylene groups, which originate from the saturated lipids in the 
malaria infected cells, Table 2 [55,56]. 
Pf1 vs Pf10 and Pv1 vs Pv10. The band of about 2930 cm− 1 in the PC- 
1 and PC-2 loadings for Pf1 vs Pf10 and Pv1 vs Pv10, respectively, 
indicate the still existing disorder in the membrane caused by Plasmo-
dium activity as well as the mixing of Plasmodial membranes (Fig. 5B, 
and 6B) [32,56]. Therefore, the amplification of the 2930 cm− 1 band 
reflect the change in the environment of the CH3 groups in proteins 
towards the more polar [57]. This indicates the normalization of the 
erythrocyte membrane and the return to the state typical for healthy 
erythrocytes which is expected on the 10th day of hospitalization. 
Pf1 vs Pv1. The positive loadings on PC-2 indicate on the 2830 cm− 1 
and 2890 cm− 1 bands due to overtone vibration, Glu and also PC 
asymmetric CH2 vibrations, that specify Pf1. The opposite, negative PC- 
2 loadings, bands at 2721 cm− 1, 2761 cm− 1, which are overtones of 
Fig. 5. Principal Component Analysis applied to Raman spectra of single RBCs, showing a general separation between patients infected with P. falciparum malaria 
parasites on the 1st day of hospitalization (red dots) and 10th day of hospitalization (pink dots); (A) PC-1 vs PC-3 scores plot and PC-3 loading plot, 1200–1000 cm− 1 
range; (B) PC-1 vs PC-3 scores plot and PC-1 loading plot, 3000–2700 cm− 1 range; (C) PC-1 vs PC-3 scores plot and PC-3 loading plot, 1500–1200 cm− 1 range; (D) PC- 
1 vs PC-2 scores plot and PC-2 loading plot, 1700–1500 cm− 1 range; excitation laser line at 514.5 nm. 
Fig. 6. Principal Component Analysis applied to Raman spectra of single RBCs, showing a general separation between patients infected with P. vivax malaria 
parasites on the 1st day of hospitalization (blue dots) and 10th day of hospitalization (turquoise dots); (A) PC-1 vs PC-3 scores plot and PC-3 loading plot, 
1200–1000 cm− 1 range; (B) PC-1 vs PC-4 scores plot and PC-4 loading plot, 3000–2700 cm− 1 range; (C) PC-1 vs PC-3 scores plot and PC-3 loading plot, 
1500–1200 cm− 1 range; (D) PC-2 vs PC-3 scores plot and PC-2 loading plot, 1700–1500 cm− 1 range; excitation laser line at 514.5 nm. 
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heme and Asp vibrations, respectively, and 2872 cm− 1, 2898 cm− 1 and 
2928 cm− 1 assigned to the methylene asymmetric stretching vibrations 
are characterized Pv1 (Fig. 7B). The methylene asymmetric stretching 
vibrations primarily indicate changes, disorder, that have occurred in 
the lipid bilayer of the erythrocyte, which seem to be dominated in the 
P. vivax infection. The presence of the Raman shifts of the selected amino 
acids, Glu and Asp, indicates the importance of the transport and 
metabolism of the carbohydrates found in red blood cells [58]. 
Pf10 vs Pv10. The C-H stretch area shows a separation in the PC-2 vs 
PC-3 scores plot for the last measurement day, comparing the cases of 
infection by each of the parasite species. The Pv10 is marked by the 
negative loadings on the PC-3 plot, by 2714 cm− 1 (2 × ν4; deoxyHb), 
2764 cm− 1 (2 ×ν4; oxyHb), 2891 cm− 1 (PC-outer), 2930 cm− 1, while 
Pf10 is signified by positive loadings, 2751 cm− 1 (2 × ν(CH2), PC-outer), 
2801 cm− 1, 2914 cm− 1 (2 ×δCH2, DLPE-inner), 2967 cm− 1 (νasym CH3) 
(Fig. 8B). There are many characteristic bands of phospholipids, derived 
from the components of the inner- and outer- layer, and many of them 
are caused by P. falciparum. This is consistent with the data that the total 
lipid content of the infected RBCs is much higher than that of the healthy 
ones [56]. Therefore, this increased lipid content is probably due to the 
Plasmodial membrane phospholipids. 
3.4.3. Pyrrole ring stretching and the CH2/CH3 deformation region 
(1500–1200 cm− 1) 
In this spectral range, in the PC-1 vs PC-2 scores plots, many changes 
related to the phenomenon of resonance Raman enhancement of pyrrole 
ring vibrations can be noticed. A principal component of PC-1 and PC-2 
explains as much as 40% and 20% of the variability in the data in this 
Fig. 7. Principal Component Analysis applied to Raman spectra of single RBCs, showing a general separation between patients infected with malaria parasites on the 
1st day of hospitalization, P. falciparum (red dots) and P. vivax (blue dots); (A) PC-1 vs PC-2 scores plot and PC-2 loading plot, 1200–1000 cm− 1 range; (B) PC-1 vs PC- 
3 scores plot and PC-3 loading plot, 3000–2700 cm− 1 range; (C) PC-1 vs PC-2 scores plot and PC-2 loading plot, 1500–1200 cm− 1 range; (D) PC-1 vs PC-4 scores plot 
and PC-4 loading plot, 1700–1500 cm− 1 range; excitation laser line at 514.5 nm. 
Fig. 8. Principal Component Analysis applied to Raman spectra of single RBCs, showing a general separation between patients infected with malaria parasites on the 
10st day of hospitalization, P. falciparum (pink dots) and P. vivax (turquoise dots); (A) PC-1 vs PC-2 scores plot and PC-2 loading plot, 1200–1000 cm− 1 range; (B) PC- 
2 vs PC-3 scores plot and PC-3 loading plot, 3000–2700 cm− 1 range; (C) PC-1 vs PC-2 scores plot and PC-1 loading plot, 1500–1200 cm− 1 range; (D) PC-1 vs PC-2 
scores plot and PC-1 loading plot, 1700–1500 cm− 1 range; excitation laser line at 514.5 nm. 
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spectral range for Pf1 vs Pf10 and Pv1 vs Pv10, respectively, Table 3. 
Pf1 vs Pf10. The negative PC-1 loadings, that depict the 1st hospi-
talization day, is marked by 1226 cm− 1 (PE –inner layer; His), 
1307 cm− 1, 1356 cm− 1 (ν4, significant deoxy Hb marker band) and 
1419 cm− 1 bands (Glu) (Fig. 5C). The strong positive PC-1 loading is 
primarily a 1374 cm− 1 band, the Raman ν4, oxy Hb and hemozoin (Hz) 
biomarker. The other bands are the 1238 cm− 1 (ν42; Hz), 1307 cm− 1 
(ν21; Hz), 1343 cm− 1, 1398 cm− 1 (ν20; Hz), and 1431 cm− 1 (Fig. 5C). 
The formation of Hz characterizes red blood cells already in the 1st but 
also in the 10th day of hospitalization (Table 3). 
Pv1 vs Pv10. The PC-2 loading negative loading, describing the 1st 
day of hospitalization, is distinct by a band of 1354 cm− 1 (ν4, consid-
erable deoxyHb marker band) in addition to the bands of amino acids 
side chains, such as Trp or Arg, while the last day of hospitalization is 
evident by a negative loading band of 1374 cm− 1 (ν4). Other bands that 
define the 10th day of hospitalization are also 1243 cm− 1 (ν13), 
1306 cm− 1 (ν21), all due to oxy Hb, 1399 cm− 1 (ν20), originated from Hz 
and Glu (Fig. 6C). Here again, oxy Hb structure and hemozoin formation 
characterizes the red blood cells on the 10th day of hospitalization. 
Pf1 vs Pv1. The PC-3 principal component on the PC-1 vs PC-3 scores 
plot separates data with 11% data variability. The positive PC-3 loadings 
plot indicates the amide III α-helical arrangement for Pf1 and also other 
characteristic vibrations of the pyrrole ring. But there are also defor-
mation vibrations of phosphatidylcholine (PC), the phospholipid 
component of the outer layer of the erythrocyte membrane (Fig. 7 C). 
The negative PC-2 loadings plot indicates other lines typical of heme 
aggregation, Hz formation, for Pv1. The negative 1361 cm− 1 band is 
usually correlated with the indole side chain environment and indicates 
buried Trp residue [32]. This band may point to the presence of tryp-
tophan rich antigens (TRAg) [39]. 
Pf10 vs Pv10. The PC-1 vs PC-4 scores plot distinguishes patients data 
from the last day of hospitalization infected with P. falciparum and 
P. vivax. The bands for certain amino acids, such as Gln and Arg, appear 
actually for both species, but with slightly different band energies. An 
important band is represented by the signal of 1367 cm− 1 from Trp, 
depicting the Pv infected RBCs on a 10th day of hospitalization. This 
band position indicates a different local environment of Trp residue than 
that on the first day of hospitalization. The variability of the PC-1 
principal component, which separates groups, is rather high, 46% 
Table 1 
The observed Raman bands positions and their assignment for single RBCs: for 
the patients infected with P. falciparum and P. vivax malaria parasites on the 1st 
and the 10th day of hospitalization: Pf1 vs Pf10, Pv1 vs Pv10, Pf1 vs Pv1 and Pf10 
vs Pv10; 1200–1000 cm− 1 range, 514.5 nm laser line.  
Patients    Assignments[4,5,28–31,33,34,36,41,42, 
51,59] 
Pf1 Pf10 Pv1 Pv10  
Raman band positions [cm− 1]  
Pf1 vs 
Pf10          
1013     Phe 
1037       νC-O, Ser   
1068     νsym C-C (trans), Arg 
1080       νsym C-C (gauche); PE, inner layer   
1090     ν23, ν(Cβ-C1)asym, (oxyHb); νsym C-C 
(gauche); ν( O-P-O-); SM-inner layer 
1102       νsym PO2-   
1120     ν22, ν(pyr half-ring)asym, (deoxyHb) 
1138       νC-O, Asp, Glu 
1152       νC-O, Thr   
1170     δC-OH, Tyr; γ(CH2), Ser 
Pv1 vs 
Pv10            
1033   νC-O, Ser       
1055 νsym C-C (trans)       
1086 ν23, ν(Cβ-C1) asym; νsym C-C (gauche);     
1103   νsym PO2-     
1122   ν22, ν(pyr half-ring)asym, (deoxyHb); νC-C, 
PE-inner     
1154   νC-O, Thr       
1170 ν30, ν(pyr half-ring)asym; δC-OH, Tyr; 
γ(CH2), Ser 
Pf1 vs Pv1        
1032       νC-O, Ser     
1130   νC-C (trans); PE- inner layer 
1147       νC-O, Asp, Glu     
1170   ν30, ν(pyr half-ring)asym; δC-OH, Tyr; 
γ(CH2), Ser 
1179       δC-OH, Tyr; γ(CH2), Ser 
Pf10 vs 
Pv10          
1025     νC-O, Ser   
1066     νsym C-C (trans); Arg   
1090     ν23, ν(Cβ-C1)asym, (oxyHb); νsym C-C 
(gauche);       
1124 ν22, ν(pyr half-ring)asym, (deoxyHb); νC-C, 
PE-inner       
1170 ν30, ν(pyr half-ring)asym; δC-OH, Tyr; 
γ(CH2), Ser  
Table 2 
The observed Raman bands positions and their assignment for single RBCs: for 
the patients infected with P. falciparum and P. vivax malaria parasites on the 1st 
and the 10th day of hospitalization: Pf1 vs Pf10, Pv1 vs Pv10, Pf1 vs Pv1 and Pf10 
vs Pv10; 3000–2700 cm− 1 range, 514.5 nm laser line.  
Patients    Assignments[5,27–30,32–34, 
51,59] 
Pf1 Pf10 Pv1 Pv10  
Raman band positions 
[cm− 1]     
Pf1 vs Pf10          
2798     2 × ν20, ν(pyr quater-ring) 
(oxyHb)   
2824     2 × ν(CN), Glu; 2 × ν(CC), Trp 
2833       2 × ν(CN), Glu   
2873     νasym (CH2) 
2882       νasym (CH2)   
2932     νasym (CH3); ν11 + ν41 
2968       νasym (CH3) in-plane   
2975     νasym (CH3) in-plane 
Pv1 vs Pv10              
2719 2 × ν4 (deoxyHb)     
2752   2 × ω(CH2), PC-outer     
2848   νsym (CH2) (lipids); PC, SM 
–outer layer       
2869 νasym (CH2)     
2883   νasym (CH2); DLPE- inner layer       
2933 νasym (CH3); ν11 + ν41       
2940 νsym (CH2) (lipids); PE-inner 
Pf1 vs Pv1            
2721   2 × ν4 (deoxyHb)     
2761   2 × ν4 (oxyHb); 2 × δ(CH3), 
Asp 
2830       2 × ν(CN), Glu     
2872   νasym (CH2) 
2890       νasym (CH2), PC-outer; νsym 
(CH2 + CH3)     
2898   νsym (CH2), νsym (NH3+), PE- 
inner     
2928   νasym (CH3), PC-outer; ν11 
+ ν41 
Pf10 vs Pv10              
2714 2 × ν4 (deoxyHb)   
2751     2 × ω(CH2), PC-outer layer       
2764 2 × ν4 (oxyHb)   
2801     2 × ν20, ν(pyr quater-ring) 
(oxyHb)       
2867 νasym (CH2)       
2891 νasym (CH2), PC-outer layer   
2914     2 × δ(CH2), DLPE-inner layer       
2930 νasym (CH3); PC-outer; ν11 
+ ν41   
2967     νasym (CH3) in-plane  
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(Fig. 8C). The signal from unsaturated fatty acids in the lipids for Pf10 is 
noteworthy. 
3.4.4. Core size marker band region (1700–1500 cm− 1) 
Pf1 vs Pf10. This spectral range shows the separation in the PC-1 vs 
PC-4 scores plot, for the analyzed model of RBCs infected with 
P. falciparum, and is described by a variability of PC-1 equal to 77%. The 
positive shifts in the PC-1 loadings plot, showing the characteristics on 
10th day of treatment, marks the band 1562 cm− 1 (ν2) resulting from 
Hz, and 1639 cm− 1 (ν10, and Arg). The first day of hospitalization is 
featured by 1586 cm− 1 (ν38, Hz and Glu), 1577 cm− 1 (Asp), 1609 cm-1 
(ν19), Fig. 5D. 
Pv1 vs Pv10. We have observed a variability of the marker bands in 
the PC-2 vs PC-4 scores plot (Fig. 6D). The first day of hospitalization is 
characterized by 1525 cm− 1 (ν2 and Lys), 1574 cm− 1 (Asp), 1609 cm− 1 
(ν19), in the positive PC-2 loadings plot. The last day of hospitalization is 
distinguished by marker bands, 1561 cm− 1 from ν2, 1587 cm− 1 from ν37, 
and 1638 cm− 1 associated with Gln and ν10. 
Pf1 vs Pv1. The positive PC-5 loadings are indicative for the first day 
of P. falciparum, and is differentiated by vibrations at: 1528 cm− 1 orig-
inated from ν28 of Hz and also Lys, 1587 cm− 1 originated from ν32 of Hz 
and Gln and 1625 cm− 1 due to amino acids, Lys and Tyr. The positive 
PC-4 loadings plot describes the first day of hospitalization with P. vivax 
infection, and shows the 1511 cm− 1 bands from Trp, then 1544 cm− 1, 
1561 cm− 1 and 1638 cm− 1 from ν13, ν2 and ν10, respectively (Fig. 7D). 
The PC-5 principal component separates the two modeled groups Pf1 
and Pv1 which is mainly due to the different structure of the heme, 
which, is Hz aggregates already formed or the oxy-Hb structure, 
respectively. 
Pf10 vs Pv10. The PC-2 vs PC-3 scores plot shows a 9% variance, due 
to PC-2, that models data specifying the 10th day of hospitalization for 
infection with P. falciparum and P. vivax. The PC-2 principal component 
differentiates the ν2 and ν19 vibrations indicating oxy-Hb for 
P. falciparum infection in relation to P. vivax vibrations 1562 cm− 1 of 
Glu, 1587 cm− 1 coming from ν2 and Gln and 1638 cm− 1 due to ν10 and 
Arg (Fig. 8D). For the infected P. falciparum cells, structural changes in 
the heme become typical, while for the infected P. vivax cells also sig-
nificant are vibrations indicating Hz and amino acids such as Glu, Gln 
and Arg. The relevant data, band positions and assignments are provided 
in Table 4. 
4. Summary and Conclusions 
For the first time to our knowledge the differences in red blood cells 
caused by protozoa, P. falciparum and P. vivax, the most common Plas-
modia species causing malaria, were discriminated using Raman 
spectroscopy. 
The corresponding to P. falciparum spectroscopic data are more 
scattered than that of P. vivax, and this characteristic applies to all of the 
Table 3 
The observed Raman bands positions and their assignment for single RBCs: for 
the patients infected with P. falciparum and P. vivax malaria parasites on the 1st 
and the 10th day of hospitalization: Pf1 vs Pf10, Pv1 vs Pv10, Pf1 vs Pv1 and Pf10 
vs Pv10; 1500–1200 cm− 1 range, 514.5 nm laser line.  
Patients Assignments[5,28,29,31,33,34,42,48,51,59] 
Pf1 Pf10 Pv1 Pv10 
Raman band positions [cm− 1] 
Pf1 vs Pf10  
1226       νasymPO2-, PE –inner layer; His   
1238     ν42, δ(CmH), Hz; ν(CO), ν(CC), Tyr 
1307       saturated fatty acids in lipids   
1343     ν41, ν(pyr half-ring)sym; δ(CH), endoplasmic 
reticulum; Glu 
1356       ν4, ν(pyr half-ring)sym,(deoxyHb)   
1374     ν4, ν(pyr half-ring)sym (oxyHb); Hz; PC-outer 
layer   
1398     ν20, ν(pyr quater-ring); Hz; Asp 
1419       δ(CH2), DLPE–inner layer; Glu   
1431     ν28, ν(CαCm) sym; 
Pv1 vs Pv10        
1229 ν13 or ν42, δ(CmH) (oxy Hb); νasymPO2-, PE –inner 
layer       
1243 ν13, (oxy Hb)     
1277   δ(CH), ν(CN), Trp       
1306 ν21, δ(CmH) (oxy Hb);     
1331   δ(CH3), Trp; Arg       
1340 ν41, ν(pyr half-ring)sym; δ(CH), endoplasmic 
reticulum; Glu     
1354   ν4, ν(pyr half-ring)sym (deoxyHb)       
1374 ν4, ν(pyr half-ring)sym (oxyHb)       
1399 ν20, ν(pyr quater-ring); Hz; Asp     
1416   δ(CH2), DLPE-inner layer 
Pf1 vs Pv1  
1278       amide III (α-helix); ν(CN), Trp     
1306   ν21, δ(CmH), Hz; 
1317       ν23 + ν26 ν(CαCβ)+ δ(CαCm); Glu     
1361   δs(CH3), Trp 
1385       δs(CH3), Asp     
1398   ν20, ν(pyr quater-ring); Hz; Glu 
1419       ν28, ν(CαCm) sym (deoxyHb);     
1430   ν28, ν(CαCm) sym (deoxyHb); Trp 
1444       δ(CH2), PC-outer layer 
Pf10 vs Pv10        
1236 ν42, δ(CmH), Hz; ν(CO), ν(CC), Tyr   
1267     amide III (α-helix), ν(CO), ν(CC), Tyr; δ(=CH) in- 
plane, unsaturated fatty acids in lipids   
1287     δ(COH), Asp, Gln       
1314 δ(CH), Trp       
1367 ν4, ν(pyr half-ring)sym (oxyHb); Asp   
1386     ν4, ν(pyr half-ring)sym (oxyHb); δ (CH3), Asp       
1394 ν20, ν(pyr quater-ring);   
1415     ν(CN), Gln       
1440 γ(CH2), PE, SM; His   
1481     δ(CH3), Phe  
Table 4 
The observed Raman bands positions and their assignment for single RBCs: for 
the patients infected with P. falciparum and P. vivax malaria parasites on the 1st 
and the 10th day of hospitalization: Pf1 vs Pf10, Pv1 vs Pv10, Pf1 vs Pv1 and Pf10 
vs Pv10; 1700–1500 cm− 1 range, 514.5 nm laser line.  
Patients Assignments[5,28,29,31,33,34,42,48,51] 
Pf1 Pf10 Pv1 Pv10 
Raman band positions [cm− 1] 
Pf1 vs Pf10    
1562     ν2, ν(CβCβ)asym, (oxyHb) 
1577       ν(COO-), Asp 
1586       ν37, ν(CαCm)asym, Hz; δ(NH2), Glu 
1609       ν19, ν(CαCm)asym   
1639     ν10, ν(CαCm)asym (oxyHb); Arg   
1654     amide I (α) 
Pv1 vs Pv10      
1525   νsym(NH3+), Lys       
1561 ν2, ν(CβCβ)asym, (oxyHb)     
1574   ν2, ν(CβCβ)asym, Hz; νasym (COO-), Asp       
1587 ν37, ν(CαCm)asym, Hz; δ(NH2), Gln     
1609   ν19, ν(CαCm)asym       
1638 amide I (α) ; ν10, ν(CαCm)asym (oxyHb); Arg 
Pf1 vs Pv1      
1511   ν(CN), Trp 
1528       ν38, ν (pyr breathing); Hz; νsym(NH3+), Lys     
1544   ν13, ν (pyr breathing); Trp     
1561   ν2, ν(CβCβ)asym, (oxyHb) 
1587       ν37, ν(CαCm)asym, Hz; δ(NH2), Gln 
1625       ν10; Hz; ν(C = C), Tyr, Lys     
1638   amide I (α); ν10, ν(CαCm)asym (oxyHb); Arg 
Pf10 vs Pv10        
1562 ν2, ν(CβCβ)asym, νasym (COO-), Glu   
1569     ν2, ν(CβCβ)asym, (oxyHb)       
1587 ν37, ν(CαCm)asym, Hz; δ(NH2), Glu   
1609     ν19, ν(CαCm)asym       
1638 amide I (α) ; ν10, ν(CαCm)asym (oxyHb); Arg  
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spectral ranges in the measurements (Figs. 5–8). This observation seems 
to be connected with other specificity of changes in erythrocytes 
possibly due to parasite considerable heterogeneity. 
The differences observed in this spectral range on the first day of 
hospitalization for P. falciparum versus P. vivax in the 1200–1000 cm− 1 
range fluctuate by 8% due to the second component of PC-3. More sig-
nificant, the difference observed on the tenth day of hospitalization 
differs significantly in the second PC-2 loadings plot with the high 
percentage of variation, equal to 26%. This spectral range describes the 
acyl backbone vibrations. It consists of many C-C bonds, and thus allow 
to determine the intra-chain phospholipids organization. There are 
noticeable changes in membrane proteins amino acids content. For 
P. falciparum there is Asp, Glu, Ser content enhancement. While for 
P. vivax there is Tyr content increase as well as changes in the cytoplasm 
membrane inner layer. On the tenth day of hospitalization, when the 
healing process is advanced, the greatest difference in the effects caused 
by both species of the parasitic protozoa is observed, which is probably 
related to the tropism of P. vivax towards reticulocytes. It is necessary to 
point out the observed ambiguities in assignments in the scope charac-
terizing structural changes in the membrane may be caused by a sig-
nificant amount of Plasmodium lipids and proteins in the composition of 
the membrane. 
The pyrrole ring stretching region, 1500–1200 cm− 1, contains some 
discriminating changes. When comparing the spectra from the first and 
tenth day of hospitalization, considering these spectroscopic data as a 
comparison of respectively infected and healthy RBCs, the variability in 
the heme structure is dominant, which is indicated primarily by the v4 
oxidation state marker band (see Fig. 4). In addition to the heme marker 
vibrations, there are also vibrations characteristic of Hemozoin (Hz), 
aggregated forms of heme, and Raman bands associated with the protein 
side chains, e.g. Trp, Tyr, Arg and Asp, see Table 3. The differences 
between the results induced by the two species of parasites appearing on 
the first day of hospitalization indicate the alterations in heme vibra-
tions as characteristic of P. falciparum, while the presence of aggregated 
forms of heme, and Hz as well as Trp and Glu side chains for P. vivax. The 
strong negative loadings at c.a. 1360 cm− 1 is indicative for the P. vivax 
infected RBCs on the first day of hospitalization pointing to the Trp 
band, Fig. 7C. The 1361 cm− 1 band, of Trp increases if the environment 
is hydrophobic, which is in this case. The presence of the Trp signal 
seems to indicate the process of ligand-receptor complex formation as a 
result of P. vivax invasion. The invasion of P. falciparum occurs with the 
basigin receptor which requires glycosylation involved with the aspartic 
acid groups. The positive PC-3 loading at 1385 cm− 1 is attributed to the 
Asp vibrations and may mark a formation a receptor–ligand connection. 
The tenth day of hospitalization was ascertained by Asp 1386 cm− 1 and 
Trp 1367 cm− 1 vibrations for P. falciparum and P. vivax, respectively, 
Table 3. The vibration observed for P. vivax for the Trp indole ring 
significantly shifted towards higher wavenumbers which may indicate a 
very strong hydrophobic interaction. 
Core size marker band region, 1700–1500 cm− 1 considering that at 
the beginning of hospitalization patients infected with Plasmodium the 
strong positive PC-5 loadings at 1587 cm− 1 can be observed for the 
P. falciparum which may be attributed to the Gln vibrations, Fig. 7D. It 
seems to indicate the formation of a ligand-receptor complex by 
P. falciparum Erythrocyte Membrane Protein 1 (PfEMP1). Whereas at the 
beginning of hospitalisation patients with P. vivax the shift observed at 
1544 cm− 1 PC-5 negative loadings is due to Trp an indole ring vibration, 
and it seems to be consistent with the previously discussed 1361 cm− 1 
vibration, which indicates the invasion stage of the parasite, the for-
mation of the ligand-receptor complex - Transferrin receptor (TfR). The 
tenth day of hospitalization is distinguished with a 9%, variance of PC-2 
due to vibrations typical for heme (in the P. falciparum case) and to 
heme, and also amino acids: Glu, Gln and Arg, (in P. vivax case). Raman 
spectroscopy distinguishes ligand-receptor interactions between 
different species of the parasite and human host erythrocytes, although 
they exhibit considerable heterogeneity and molecular evolution, which 
can lead to the observed data dispersion. Despite all the limitations in 
obtaining a simple answer, which was to distinguish the effect of the 
specious of Plasmodium on blood cells, it seems we have been able to 
observe the trend of change characteristic of each type of Plasmodium. 
Due to the intention of our work to contribute to the advancement of 
translational medicine, Raman research do not require much effort in 
routine hospital work, as the blood smear didn’t need any staining or 
complicated preparation, and at the moment some insight into the 
specifics of malaria infection. This gives a likely possibility to use of 
Raman spectroscopy in clinical practise in future. 
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The ring-stage of Plasmodium falciparum observed in RBCs of hospitalized malaria 
patients, Analyst 140 (2015) 8007–8016, https://doi.org/10.1039/c5an01598g. 
[5] A.G. Maier, K. Matuschewski, M. Zhang, M. Rug, Plasmodium falciparum, Trends 
Parasitol. 35 (2019) 481–482, doi.org/10.1016/j.pt.2018.11.010. 
[6] G.E. Weiss, B.S. Crabb, P.R. Gilson, Overlaying molecular and temporal aspects of 
malaria parasite invasion, Trends Parasitol. 32 (2016) 284–295, doi.org/10.1016/ 
j.pt.2015.12.007. 
[7] I. Mueller, M.R. Galinski, J.K. Baird, J.M. Carlton, D.K. Kochar, P.L. Alonso, H. 
A. del Tortillo, Key gaps in the knowledge of Plasmodium vivax, a neglected human 
malaria parasite, Lancet Infect. Dis. 9 (2009) 555–566, https://doi.org/10.1016/ 
S1473-3099(09)70177-X. 
[8] J.K. Baird, Evidence and implications of mortality associated with acute 
Plasmodium vivax malaria, Clin. Microbiol. Rev. 26 (2013) 36–57, https://doi.org/ 
10.1128/CMR.00074-12. 
[9] N.M. Douglas, G.J. Pontororing, D.A. Lampah, T.W. Yeo, E. Kenangalem, J. 
R. Poespoprodjo, A.P. Ralph, M.J. Bangs, P. Sugiarto, N.M. Anstey, R.N. Price, 
Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, 
Indonesia, BMC Med. 12 (217) (2014) 1–13, doi.org/10.1186/s12916-014-0217-z. 
[10] P.W. Gething, I.R.F. Elyazar, C.L. Moyes, D.L. Smith, K.E. Battle, C.A. Guerra, A. 
P. Patil, A.J. Tatem, R.E. Howes, M.F. Myers, D.B. George, P. Horby, H.F. 
L. Wertheim, R.N. Price, I. Mueller, J.K. Baird, S.I. Hay, A long neglected world 
malaria map: Plasmodium vivax endemicity in 2010, PLoS Negl. Trop. Dis. 6 
(1–12) (2012), 1814, https://doi.org/10.1371/journal.pntd.0001814. 
[11] Diagnostic testing for malaria, World Health Organization, 〈https://www.who.in 
t/activities/diagnostic-testing-for-malaria〉 (Accessed 10.03.2021). 
[12] Malaria Diagnosis (U.S.) – Microscopy, Diagnostic Tools, Centers for Disease 
Control and Prevention, 〈https://www.cdc.gov/malaria/diagnosis_treatmen 
t/diagnostic_tools.html#〉 (Accessed 10.03.2021). 
[13] A.F. Cowman, J. Healer, D. Marapana, K. Marsh, Malaria: BIOLOGY AND DISEAse, 
Cell 167 (2016) 610–624, doi.org/10.1016/j.cell.2016.07.055. 
[14] J. Czepiel, S. Goldman, A. Szlauer-Stefańska, A. Mielimonka, G. Biesiada, 
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G. Kowalczyk, M. Kurdziel, M. Birczyńska, G. Biesiada, T. Mach, A. Garlicki, 
Human erythrocytes analyzed by generalized 2D Raman correlation spectroscopy, 
J. Mol. Struct. 1069 (2014) 305–312, https://doi.org/10.1016/j. 
molstruc.2014.03.023. 
[32] A.T. Tu, Raman Spectroscopy in Biology: Principles and Applications, John Wiley 
& Sons, New York, 1982. 
[33] E. Lenzi, S. Dinarelli, G. Longo, M. Girasole, V. Mussi, Multivariate analysis of 
mean Raman spectra of erythrocytes for a fast analysis of the biochemical signature 
of ageing, Talanta 221 (1–8) (2021), 121442, https://doi.org/10.1016/j. 
talanta.2020.121442. 
[34] A.F. Cowman, B.S. Crabb, Invasion of red blood cells by malaria parasites, Cell 124 
(2006) 755–766, https://doi.org/10.1016/j.cell.2006.02.006. 
[35] M. Zhang, P. Faou, A.G. Maier, M. Rug, Plasmodium falciparum exported protein 
PFE60 influences Maurer’s clefts architecture and virulence complex composition, 
Int. J. Parasitol. 48 (2018) 83–95, doi.org/10.1016/j.ijpara.2017.09.003. 
[36] C. Crosnier, L.Y. Bustamante, S.J. Bartholdson, A.K. Bei, M. Theron, M. Uchikawa, 
S. Mboup, O. Ndir, D.P. Kwiatkowski, M.T. Duraisingh, J.C. Rayner, G.J. Wright, 
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum, 
Nature 480 (2011) 534–537, https://doi.org/10.1038/nature10606. 
[37] D.C. Stein, V. Briken, Microbial glycobiology!Antigenic variation of microbial 
surface glycosylated molecules, Struct. Relev. Appl. (2010) 819–835, https://doi. 
org/10.1016/B978-0-12-374546-0.00041-9. 
[38] J. Gruszczyk, R.K. Huang, L.-J. Chan, S. Menant, C. Hong, J.M. Murphy, Y.-F. Mok, 
M.D.W. Griffin, R.D. Pearson, W. Wong, A.F. Cowman, Z. Yu, W.-H. Tham, Cryo- 
EM structure of an essential Plasmodium vivax invasion complex, Nature 559 
(2018) 135–139, doi.org/10.1038/s41586-018-0249-1. 
[39] U. Kanjee, G.W. Rangel, M.A. Clark, M.T. Duraisingh, Molecular and cellular 
interactions defining the tropism of Plasmodium vivax for reticulocytes, Curr. 
Opin. Microbiol. 46 (2018) 109–115, doi.org/10.1016/j.mib.2018.10.002. 
[40] H. Takeuchi, Raman structural markers of tryptophan and histidine side chains in 
proteins, Biopolymers 72 (2003) 305–317. 
[41] U. Kanjee, G.W. Rangel, M.A. Clark, M.T. Duraisingh, Molecular and cellular 
interactions defining the tropism of Plasmodium vivax for reticulocytes, Curr. 
Opin. Microbiol. 46 (2018) 109–115, doi.org/10.1016/j.mib.2018.10.002. 
[42] J.M. Pisciotta, P.F. Scholl, J.L. Shuman, V. Shualev, D.J. Sullivan, Quantitative 
characterization of hemozoin in Plasmodium berghei and vivax, Int. J. Parasitol. 
Drugs Drug Resist. 7 (2017) 110–119, doi.org/10.1016/j.ijpddr.2017.02.001. 
[43] G. Fontecha, A. Pinto, D. Escobar, G. Matamoros, B. Ortiz, Genetic variability of 
Plasmodium falciparum histidine‑rich proteins 2 and 3 in Central America, Malaria 
J. 18 (2–10) (2019) 31, https://doi.org/10.1186/s12936-019-2668-3. 
[44] M.C. Leclerc, P. Durand, C. Gauthier, S. Patot, N. Billotte, M. Menegon, C. Severini, 
F.J. Ayala, F. Renaud, Meager genetic variability of the human malaria agent 
Plasmodium vivax, PNAS 101 (2004) 14455–14460, https://doi.org/10.1073/ 
pnas.0405186101. 
[45] B.M. Cooke, N. Mohandas, R.L. Coppel, The malaria-infected red blood cell: 
structural and functional changes, Adv. Parasitol. 50 (2001) 1–86, 0065-308X. 
[46] J. Czepiel, M. Kozicki, P. Panasiuk, M. Birczyńska, A. Garlicki, A. Wesełucha- 
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